Navigation Links
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Date:8/26/2010

company entirely dedicated to vaccines.  Every day, the company invests more than EUR 1 million in research and development.  For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us

Forward Looking StatementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Forward-looking statements are statements that are not historical facts.  These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions.  Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that co
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
2. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
3. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
4. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
5. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
6. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
10. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
11. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)... May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 31, 2013, before market on Tuesday, May 28, 2013.  The ... 2013, at 8:00 a.m. EDT (May 28, 2013 at 8:00 ... and provide an update on recent corporate developments. ...
(Date:5/16/2013)... May 17, 2013 Singapore,s ... Switzerland,s Cytos Biotechnology AG today announced ... Phase 1 clinical trial with their H1N1 influenza vaccine candidate ... In this first Phase 1 clinical trial, the safety and ... protect against H1N1 influenza infection will be evaluated. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Four-time NASCAR Cup Series champion Jeff Gordon, known ... he is for his philanthropic activities and tireless support ... the Alabama tornado relief effort through the Jeff Gordon ... clothing for babies and children affected by the destruction. ...
... Genomic Health, Inc. (Nasdaq: GHDX ) ... the American Society of Clinical Oncology (ASCO) Annual Meeting, ... of the Onco type DX® colon cancer Recurrence ... in stage II colon cancer.  The company also will ...
Cached Medicine Technology:Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 2Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 3Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 4Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 9
(Date:5/19/2013)... At a May 6th, 2013 meeting ... Physicians (NCAPIP), the Pacific Chronic Disease Coalition (PCDC), ... Disease Directors (NACDD), presented a newly published assessment ... non-communicable diseases (NCDs) in the U.S. Associated Pacific ... Hawaii Journal of Medicine and Public Health, highlights ...
(Date:5/19/2013)... ─ Gourmands and foodies everywhere have long recognized ginger ... zing to both sweet and savory dishes; now, a ... of the spicy root also may have properties that ... of the study will be presented at the ATS ... a tightening of the bronchial tubes that carry air ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 People in Minnesota ... summer. Altman Fitness is offering its 28 Day Fat Loss ... program from the comfort of their own home. The product ... purchase. More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ ... to leave their houses now, but after using the 28 ...
(Date:5/19/2013)... Today, Zane Benefits, Inc. published ... insurance . Zane Benefits, which provides comprehensive and ... is the leader in health care reform, ... . , According to Zane Benefits’ website, many ... the value of small business health insurance for ...
(Date:5/19/2013)... TX (PRWEB) May 19, 2013 ... analysis for US, UK, Spain, Japan, Italy, Germany ... to the molecular diagnostics laboratory practice, as well ... trends with significant market impact during the next ... DNA probe and biochip technologies, test formats, detection ...
Breaking Medicine News(10 mins):Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4
... Health Corp. (Nasdaq:,WBMD) today announced the honorees of the ... of WebMD the Magazine. The third,annual WebMD Health Heroes ... vision and drive to inspire others to action., ... Cancer, Laura Ziskin, breast cancer survivor and Hollywood ...
... Trane CleanEffects(TM) May Lower Risk of, Serious Health Outcomes ... ... Inside the Home, TYLER, Texas, Nov. 11 A new ... Inc. (EH&E),in collaboration with professors at the Harvard School of Public ...
... of 2008 May Offer Little Hope for Many ... 10:30am-11:30am,card-carrying veterans visiting St. Anthony Foundation will receive ... and tea. While many,may be categorically eligible for ... through Veterans, Bond Act of 2008 (S.B. 1572, ...
... features sneak peek and tips from YOU Docs, latest ... doctors Mehmet,Oz, MD, and Michael Roizen, MD, first challenged ... York Times #1 best-seller in 2005. Now,these same physicians ... book series -- want to know, "What stands in ...
... an Important Employee Benefit for Health-Conscious ... ... BioIQ,( http://www.bioiq.com ), a leading supplier of health screening and ... and supply chain software, is offering BioIQ,s home test,kits to its ...
... Caring.com, baby boomers caring for an aging parent are playing an active ... ... San Mateo, Calif. (PRWEB) November 11, 2008 -- According to a new ... an active role when it comes to decisions about their parents, medications. ...
Cached Medicine News:Health News:WebMD Announces 2008 Health Heroes 2Health News:WebMD Announces 2008 Health Heroes 3Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 2Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 3Health News:Homeless Veterans Turn to St. Anthony's Dining Room for Help on Veterans Day 2Health News:Doctors Reveal Biology of Beauty in New Book 2Health News:Software Vendor QAD Rolls Out BioIQ Health Testing Program to National Workforce 2Health News:Boomers Play an Active Role with Parent's Medication Decisions 2
... fully automated high-throughput glass-on-glass coverslipper. The ... microscope glass slides bearing tissue sections ... quality-grade coverslips of different standard sizes ... capability of handling a large variety ...
... mountant media dispensing system eliminates ... under the coverglass. All new ... most automated staining machines. Available ... pre-filled coverglass and mountant dispensers. ...
... Trellis Infusion Catheter enables the physician to ... fluid, and disperse the agent by means ... Trellis is a multi-lumen catheter with two ... and infusion holes located between these balloons. ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i...
Medicine Products: